Dragon fruit versus soybean: impact on blood glucose of diabetic patients
DOI:
https://doi.org/10.22219/jk.v14i02.27312Abstract
Introduction: Diabetes Mellitus (DM) is a severe problem with a rapidly increasing incidence rate. DM can affect almost all segments of society worldwide. The number of individuals with DM continues to rise yearly due to the sedentary lifestyle and unhealthy eating habits prevalent in contemporary society. Objectives: This study aims to compare the effects of soymilk and red dragon fruit consumption on fasting blood glucose levels in individuals with type 2 diabetes mellitus. Methods: The research design employed in this study is quasi-experimental with a pre-test-post-test approach involving two treatment groups. The study subjects were 54 individuals with type 2 diabetes mellitus from Bukittinggi. The participants were divided into three groups: an intervention group of 18 individuals who consumed red dragon fruit daily for seven days, a second intervention group of 18 individuals who consumed soymilk daily, and a control group of 18. Comparison analysis is done using the ANOVA test. Results: The research findings indicate that the p-value is 0.035, and the calculated t-value (2.198) is greater than the tabulated t-value (2.110. Furthermore, the consumption of red dragon fruit impacted fasting blood glucose levels and blood pressure, as evidenced by a p-value of 0.018 for fasting blood glucose and a calculated t-value of 2.198, which exceeds the tabulated t-value of 2.110. The ANOVA results indicate that the effectiveness of red dragon fruit consumption is superior, with an average decrease in blood glucose levels of 32.56, compared to the effectiveness of soymilk consumption, which resulted in an average decrease of 22.50. Conclusions: Red dragon fruit is more effective in reducing blood glucose and blood pressure levels in patients with type 2 diabetes mellitus.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ade Srywahyuni, Dona Amelia, liza merianti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This journal is licensed under the a Creative Commons Attribution-ShareAlike 4.0 International License.